Table 2.

Expression of TLR4 and MyD88 in breast cancer and its relationship with clinicopathological characteristics

Feature		Total case	TLR4		χ2	P value	Total case	MyD88		χ2	P value
			-	+				-	+
Age	≤ 50	37	11	12	0.455b	0.341	37	22	15	0.050b	1.000
	> 50	23	21	16			23	13	10
Menopausal state	Pre-menopausal	35	18	17	0.122b	0.796	35	20	15	0.049b	1.000
	Postmenopausal	25	14	11			25	15	10
Family history of malignancy	Yes	3	1	2	0.508b	0.594	3	1	2	0.812a	0.565
	No	57	31	26			57	34	23
Tumor size	T1	18	8	10	9.102a	0.017	18	11	9	10.63a	0.009
	T2	32	22	10			32	24	8
	T3	8	1	7			8	2	6
	T4	2	1	1			2	0	2
Axilla lymph node status	Yes	37	16	21	12.75a	0.001	37	17	20	6.094a	0.017
	No	23	16	7			23	18	5
The number of lymph node metastasis	1-3	15	5	10	1.722a	0.445	13	5	8	0.768a	0.802
	4-9	18	10	8			21	11	10
	≥ 10	5	2	3			4	2	2
Tumor stage	I/II	41	27	14	8.155b	0.006	32	21	12	0.634b	0.447
	III	19	5	14			28	15	13
Histological grade	I/II	23	11	12	0.455b	0.341	27	17	10	0.433a	0.602
	III	37	21	16			33	18	15
Distance Metastasis	Yes	7	2	5	4.926a	0.037	7	1	6	6.326b	0.017
	No	53	30	23			53	34	19
	Lung	5	2	3	0.058a	1.000	5	1	4	3.733a	0.143
	Bone	2	1	1			2	2	0

^aFisher’s test;

^bχ² (Chi-square) test.